Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Bryn Mawr Capital Management LLC

Bryn Mawr Capital Management LLC raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 48.9% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,085 shares of the medical equipment provider’s stock after purchasing an additional 685 shares during the quarter. Bryn Mawr Capital Management LLC’s holdings in Intuitive Surgical were worth $1,088,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the business. Massachusetts Financial Services Co. MA acquired a new position in shares of Intuitive Surgical in the 3rd quarter worth approximately $558,807,000. FMR LLC grew its position in shares of Intuitive Surgical by 8.3% in the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after acquiring an additional 838,793 shares in the last quarter. Wilmington Savings Fund Society FSB grew its position in shares of Intuitive Surgical by 15,322.2% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after acquiring an additional 552,058 shares in the last quarter. Strategic Financial Concepts LLC grew its position in shares of Intuitive Surgical by 50,740.8% in the 4th quarter. Strategic Financial Concepts LLC now owns 312,671 shares of the medical equipment provider’s stock worth $163,202,000 after acquiring an additional 312,056 shares in the last quarter. Finally, State Street Corp grew its position in shares of Intuitive Surgical by 1.4% in the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock worth $7,393,673,000 after acquiring an additional 210,363 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity

In other news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Jamie Samath sold 188 shares of Intuitive Surgical stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $101,332.00. Following the transaction, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,720,023. This trade represents a 2.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 6,240 shares of company stock worth $3,529,040. 0.80% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the company. Citigroup lifted their target price on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Royal Bank of Canada lifted their target price on Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. CICC Research initiated coverage on Intuitive Surgical in a research report on Monday, January 27th. They issued a “neutral” rating and a $550.00 target price for the company. Wells Fargo & Company raised their price target on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Finally, Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $580.93 on Thursday. The business’s fifty day moving average price is $568.10 and its two-hundred day moving average price is $527.65. The company has a market capitalization of $206.92 billion, a P/E ratio of 90.63, a PEG ratio of 5.85 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.